Biomarker for ALS: DZNE participates in international project
Researchers at DZNE’s Ulm site are involved in an international project on the neurological disease amyotrophic lateral sclerosis…
back to overview
AVERT-MD
Movement disorders such as Parkinson's disease, essential tremor, cerebellar ataxias and Huntington's disease are complex neurological disorders whose early diagnosis is…
back to overview
7T-TGA - High-resolution MRI imaging in TGA patients: a retrospective and prospective study
Background and aims
In transient global amnesia (TGA), the patients affected suffer…
Areas of investigation/research focus
Cognitive impairment occurs frequently after stroke and has a high impact on patients’ quality of life. Different cognitive trajectories with impairment in…
back to overview
VO659-CT01
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
To get more information, please go to VICO Therapeutics
See also the information on…
M-Star
Randomized, double-Blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of BHV-3241 in subjects with multiple system atrophy
Multisystem atrophy (MSA) is a…
back to overview
IONIS-MAPTRX-CS1
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of…
